Supernus Trokendi XR 50mg Capsules: Failed Dissolution Specifications Recall
Supernus Pharmaceuticals recalls Trokendi XR 50mg extended-release capsules due to failed dissolution specifications. This may affect safety and requires checking product details.
Lower-risk recall
Failed dissolution specifications.
What happened, in plain English
Supernus Pharmaceuticals is recalling Trokendi XR 50mg extended-release capsules because they failed dissolution specifications. This means the medication may not release properly in the body, potentially affecting treatment effectiveness. Read more at govinfonow.com/recall/838274-supernus-trokendi-xr-50mg-capsules-failed-dissolution-specifications-recall.
Source Summary by GovInfoNow · govinfonow.com/recall/838274-supernus-trokendi-xr-50mg-capsules-failed-dissolution-specifications-recall · Updated September 16, 2026 · FDA enforcement record: FDA #D-0833-2026
Cite this page
“Supernus Trokendi XR 50mg Capsules: Failed Dissolution Specifications Recall.” GovInfoNow, updated September 16, 2026. https://govinfonow.com/recall/838274-supernus-trokendi-xr-50mg-capsules-failed-dissolution-specifications-recall. Based on FDA recall #D-0833-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0833-2026%22&limit=1).
Why it’s dangerous
The capsules failed to dissolve correctly as intended, which could lead to improper medication release. This might reduce the drug's effectiveness in managing conditions like seizures or migraines.
Who’s affected
Prescription patients who have the Trokendi XR 50mg capsules with NDC 17772-102-30 and lot number 2145283. People with seizure disorders or other conditions treated with this medication are most at risk.
How to tell if you have this one
Check for the NDC code 17772-102-30 and lot number 2145283 on the packaging. The product was manufactured by Catalent Pharma Solutions in Winchester, KY and distributed by Supernus Pharmaceuticals in Rockville, MD.
- Brand
Supernus Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC code 17772-102-30 and lot number 2145283 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 9 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0833-2026 (August 31, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0833-2026 to see it in context.
- Plain-language summary written by qwen3:4b on September 16, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.